Physician

Alex Todd Hirsh, M.D.

According to 2025 Medicare claims, Alex Hirsh, M.D. (NPI: 1174639181) practices dermatology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Cuyahoga, OH. This provider's primary affiliated billing organization is FRED S HIRSH MD INC (NPI: 1114095775; TIN: 341234050) and primary practice location at 44060-5318.

Hirsh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,383 traditional Medicare patients, billed 7,911 HCPCS/CPT codes, and received $329,231 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,803 prescription claims across 712 beneficiaries totaling $355,661 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 63 records totaling $32,299. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $208,837 to $329,231. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $95,152 to $355,661. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$173K$347K2015 Medicare payment: $208,837 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $245,189 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $239,148 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $279,497 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $286,639 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $344,137 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $346,731 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $327,534 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $309,285 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $329,231 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158654,705$208,837
20161,0495,727$245,189
20171,0455,380$239,148
20181,1435,994$279,497
20191,2286,203$286,639
20201,4598,095$344,137
20211,3558,088$346,731
20221,3658,003$327,534
20231,3247,404$309,285
20241,3837,911$329,231

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$178K$356K2015 Drug cost: $95,152 (USD; Tot_Drug_Cst)2016 Drug cost: $90,617 (USD; Tot_Drug_Cst)2017 Drug cost: $83,570 (USD; Tot_Drug_Cst)2018 Drug cost: $86,198 (USD; Tot_Drug_Cst)2019 Drug cost: $131,404 (USD; Tot_Drug_Cst)2020 Drug cost: $297,190 (USD; Tot_Drug_Cst)2021 Drug cost: $223,670 (USD; Tot_Drug_Cst)2022 Drug cost: $267,174 (USD; Tot_Drug_Cst)2023 Drug cost: $318,095 (USD; Tot_Drug_Cst)2024 Drug cost: $355,661 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015395939$95,152
20164261,007$90,617
20174591,059$83,570
20184911,156$86,198
20195591,336$131,404
20207011,827$297,190
20217201,839$223,670
20226731,670$267,174
20236741,718$318,095
20247121,803$355,661

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths308408$74
11102Biopsy of related skin growth, first growth448597$61
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,2452,250$57
17000Destruction of precancer skin growth, 1 growth6131,042$37
17003Destruction of precancer skin growth, 2-14 growths4112,261$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab13364$92,279
Cosentyx Sensoready (2 Pens)Secukinumab12336$86,900
Clobetasol PropionateClobetasol Propionate2407,702$12,177
Doxycycline Ir-DrDoxycycline Monohydrate11390$7,380
Doxycycline HyclateDoxycycline Hyclate2289,545$5,606

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.63$32,299Galderma Laboratories, L.P.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alex Todd Hirsh, M.D.?

Tedicare shows public-source Medicare data for Alex Todd Hirsh, M.D. (NPI 1174639181), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alex Todd Hirsh, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alex Todd Hirsh, M.D.?

Alex Todd Hirsh, M.D. is linked to FRED S HIRSH MD INC (billing NPI 1114095775) in the available physician profile data.

Does Alex Todd Hirsh, M.D. have Open Payments data?

Alex Todd Hirsh, M.D. has 63 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.